Upbeat economic data along with rebounding crude oil prices sent the markets soaring to a sharply higher close with the Dow rocketing 222 points to 17,928. Nasdaq jumped 59 points to 4,809.

On the upside

Bloomberg reported that Marketo (Nasdaq: MKTO) engaged the services of Morgan Stanley to explore strategic options including a possible sale of the company.

Dermira (Nasdaq: DERM) reported positive results from a Phase 2b clinical trial of DRM01 to treat facial acne vulgaris.

Nautilus (NYSE: NLS) reported higher first quarter earnings that topped analyst estimates.

On the downside

Epirus Biopharmaceuticals (Nasdaq: EPRS) suspended lead program BOW015 and announced the resignation of president and chief executive Amit Munshi.

Zebra Technologies (Nasdaq: ZBRA) widened first quarter losses more than expected and forecast lower second quarter revenue.

Omeros (Nasdaq: OMER) widened losses for the first quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 surged 25 points to 2,084. Bitcoin lost $4 to $451.